Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 312

1.

Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.

Hendriks LE, Troost EG, Steward A, Bootsma GP, De Jaeger K, van den Borne BE, Dingemans AM.

Acta Oncol. 2014 Jul;53(7):945-51. doi: 10.3109/0284186X.2014.906746. Epub 2014 Apr 23.

PMID:
24754845
2.

Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.

Bernhardt D, Adeberg S, Bozorgmehr F, Opfermann N, Hoerner-Rieber J, König L, Kappes J, Thomas M, Herth F, Heußel CP, Warth A, Debus J, Steins M, Rieken S.

J Neurooncol. 2017 Aug;134(1):205-212. doi: 10.1007/s11060-017-2510-0. Epub 2017 May 30.

PMID:
28560661
3.
4.

Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).

Bohlen G, Meyners T, Kieckebusch S, Lohynska R, Veninga T, Stalpers LJ, Schild SE, Rades D.

Clin Neurol Neurosurg. 2010 Apr;112(3):183-7. doi: 10.1016/j.clineuro.2009.11.004. Epub 2009 Dec 3.

PMID:
19962229
5.

Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.

Rades D, Schild SE, Lohynska R, Veninga T, Stalpers LJ, Dunst J.

Cancer. 2007 Sep 1;110(5):1077-82.

6.

Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.

Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, Barani IJ, McDermott MW.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):303-9. doi: 10.1016/j.ijrobp.2011.06.1987. Epub 2011 Nov 11.

PMID:
22079723
7.

Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.

Viani GA, Castilho MS, Salvajoli JV, Pellizzon AC, Novaes PE, Guimarães FS, Conte MA, Fogaroli RC.

BMC Cancer. 2007 Mar 26;7:53.

8.

Gamma knife radiosurgery for treatment of cerebral metastases from non-small-cell lung cancer.

Motta M, del Vecchio A, Attuati L, Picozzi P, Perna L, Franzin A, Bolognesi A, Cozzarini C, Calandrino R, Mortini P, di Muzio N.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e463-8. doi: 10.1016/j.ijrobp.2011.02.051. Epub 2011 Apr 27.

PMID:
21530098
9.
10.

Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases.

Videtic GM, Adelstein DJ, Mekhail TM, Rice TW, Stevens GH, Lee SY, Suh JH.

Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):240-3. Epub 2006 Oct 23.

PMID:
17056192
11.

Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?

Nieder C, Nestle U, Motaref B, Walter K, Niewald M, Schnabel K.

Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):297-302.

PMID:
10661335
12.

Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.

Nieder C, Andratschke N, Grosu AL, Molls M.

Strahlenther Onkol. 2003 Jan;179(1):16-20.

PMID:
12540980
13.

Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.

Rades D, Bohlen G, Dunst J, Lohynska R, Veninga T, Stalpers L, Schild SE, Dahm-Daphi J.

Strahlenther Onkol. 2008 Jan;184(1):30-5. doi: 10.1007/s00066-008-1795-5.

PMID:
18188520
14.

Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis.

Kocher M, Maarouf M, Bendel M, Voges J, Müller RP, Sturm V.

Strahlenther Onkol. 2004 May;180(5):263-7.

PMID:
15127155
16.

Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.

Ma LH, Li G, Zhang HW, Wang ZY, Dang J, Zhang S, Yao L, Zhang XM.

J Neurosurg. 2012 Dec;117 Suppl:49-56. doi: 10.3171/2012.7.GKS121071.

PMID:
23205789
17.

Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.

Antoni D, Clavier JB, Pop M, Schumacher C, Lefebvre F, Noël G.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):630-7. doi: 10.1016/j.ijrobp.2013.02.027. Epub 2013 Apr 11.

PMID:
23582409
18.

Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.

Bernhardt D, König L, Aufderstrasse S, Krisam J, Hoerner-Rieber J, Adeberg S, Bozorgmehr F, El Shafie R, Lang K, Kappes J, Thomas M, Herth F, Heußel CP, Warth A, Marcrom S, Debus J, Steins M, Rieken S.

Clin Lung Cancer. 2018 Jul;19(4):340-345. doi: 10.1016/j.cllc.2017.12.004. Epub 2017 Dec 15.

PMID:
29373273
19.

Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation.

Rodrigus P, de Brouwer P, Raaymakers E.

Lung Cancer. 2001 May;32(2):129-36.

PMID:
11325483
20.

Management of brain metastases from non-small cell lung cancer.

Baykara M, Kurt G, Buyukberber S, Demirci U, Ceviker N, Algin E, Coskun U, Aykol S, Emmez H, Ozet A, Benekli M.

J Cancer Res Ther. 2014 Oct-Dec;10(4):915-21. doi: 10.4103/0973-1482.137939.

Supplemental Content

Support Center